We are live on ! Find out more
AQST icon

Aquestive Therapeutics
AQST

36 hedge funds and large institutions have $90.5M invested in Aquestive Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

6.88% less ownership

Funds ownership: 64.5% → 57.62% (-6.9%)

18% less funds holding

Funds holding: 44 → 36 (-8)

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

68% less capital invested

Capital invested by funds: $282M → $90.5M (-$191M)

Holders
36
Holders Change
-8
Holders Change %
-18.18%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
9
Reduced
9
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$2.16M
2
BlackRock
BlackRock
New York
+$2.15M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.52M
4
Squarepoint
Squarepoint
New York
+$377K
5
State Street
State Street
Massachusetts
+$351K

Top Sellers

1
CM
Crestline Management
Texas
-$201M
2
PA
Perceptive Advisors
New York
-$20.1M
3
PWAM
Park West Asset Management
California
-$6.9M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$2.11M
5
SFM
Sphera Funds Management
Israel
-$1.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
Bratton Capital Management
Texas
$72.5M +$145M +11,503,294 New
AllianceBernstein
2
AllianceBernstein
Tennessee
$4.1M -$2.11M -166,777 -20%
BlackRock
3
BlackRock
New York
$4.04M +$2.15M +170,396 +36%
Massachusetts Financial Services
4
Massachusetts Financial Services
Massachusetts
$2.99M +$2.16M +170,984 +56%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.14M -$1.52M -120,584 -26%
WA
6
Wasatch Advisors
Utah
$916K – – –
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$758K +$1.52M +120,302 +245,514%
BBA
8
Baker Bros. Advisors
New York
$627K – – –
Northern Trust
9
Northern Trust
Illinois
$366K +$4K +317 +0.5%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$278K +$244K +19,310 +78%
State Street
11
State Street
Massachusetts
$268K +$351K +27,780 +188%
OAM
12
Oxford Asset Management
United Kingdom
$245K -$100K -7,957 -17%
Squarepoint
13
Squarepoint
New York
$188K +$377K +29,828 New
Millennium Management
14
Millennium Management
New York
$145K +$290K +23,010 New
TCIM
15
TIAA CREF Investment Management
New York
$137K +$274K +21,725 New
Goldman Sachs
16
Goldman Sachs
New York
$132K -$7.06K -559 -3%
Wells Fargo
17
Wells Fargo
California
$124K +$240K +19,034 +2,576%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$108K +$216K +17,124 New
EGM
19
Engineers Gate Manager
New York
$89K -$156K -12,350 -47%
QSS
20
Quantitative Systematic Strategies
Florida
$72K +$144K +11,441 New
Morgan Stanley
21
Morgan Stanley
New York
$51K -$3.29K -261 -3%
California State Teachers Retirement System (CalSTRS)
22
California State Teachers Retirement System (CalSTRS)
California
$50K – – –
Bank of America
23
Bank of America
North Carolina
$50K +$95.2K +7,541 +1,533%
Victory Capital Management
24
Victory Capital Management
Texas
$32K – – –
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$28K +$56.8K +4,500 New
1
2 3

AQST Hedge Fund Activity: Q4 2018 in Review

36 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Aquestive Therapeutics (AQST) for Q4 2018, worth a combined $90.5M — down 68% from $282M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of AQST and 11 opened new positions — a net loss of 7 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $2.16M. The largest seller was Crestline Management, exiting entirely with an estimated $201M sold.

  • 36 institutional investors held Aquestive Therapeutics (AQST) as of Q4 2018, down from 44 in Q3 2018.
  • Funds reported $90.5M of Aquestive Therapeutics stock for Q4 2018, down 68% quarter-over-quarter.
  • 11 funds opened new Aquestive Therapeutics positions in Q4 2018 and 18 closed out, a net change of -7 holders.
  • The largest Aquestive Therapeutics buyer in Q4 2018 was Massachusetts Financial Services, an estimated $2.16M added.
  • The largest Aquestive Therapeutics seller in Q4 2018 was Crestline Management, an estimated $201M sold.

Based on aggregated 13F filings for Q4 2018.